SIRFLOX VNR

367

Peter Gibbs and Fred Moeslein explain the ramifications of the SIRFLOX study, the results of which open new possibilities of combining radiation targeted at liver metastases with first-line systemic treatment of unresectable metastatic colorectal cancer.